Evidence map›Paper›PMID 32946486›Full record

ArticlePloS one2020

Clinical and molecular epidemiology of invasive Staphylococcus aureus infection in Utah children; continued dominance of MSSA over MRSA.

Hillary Crandall, Aurélie Kapusta, Jarrett Killpack, Carly Heyrend, Kody Nilsson, Mandy Dickey, Judy A Daly, Krow Ampofo, Andrew T Pavia, Matthew A Mulvey and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 34 citations in OpenAlex.

  1. Population genomic variation inMicrobial genomics · 2026
    Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Genomic profiling of methicillin-sensitiveFrontiers in microbiology · 2024
    Article
  8. Article
  9. Article
  10. Trends in pediatric community-onsetAntimicrobial stewardship & healthcare epidemiology : ASHE · 2023
    Article
  11. Article
  12. Utility of Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2021
    Article
  13. Article
  14. Bioguided Isolation of Active Compounds fromMolecules (Basel, Switzerland) · 2021
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Hillary CrandallDivision of Pediatric Critical Care, Department of Pediatrics, University of Utah, Salt Lake City, Utah, United States of America.ORCID 0000-0002-5392-8457
Aurélie KapustaDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City, Utah, United States of America.ORCID 0000-0002-4131-903X
Jarrett KillpackDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City, Utah, United States of America.
Carly HeyrendPrimary Children's Hospital, Salt Lake City, Utah, United States of America.
Kody NilssonDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City, Utah, United States of America.
Mandy DickeyPrimary Children's Hospital, Salt Lake City, Utah, United States of America.
Judy A DalyPrimary Children's Hospital, Salt Lake City, Utah, United States of America.
Krow AmpofoDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City, Utah, United States of America.
Andrew T PaviaDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City, Utah, United States of America.
Matthew A MulveyDepartment of Pathology, University of Utah, Salt Lake City, Utah, United States of America.
Mark YandellDepartment of Human Genetics, University of Utah, Salt Lake City, Utah, United States of America.
Kristina G HultenDivision of Pediatric Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America.
Anne J BlaschkeDivision of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City, Utah, United States of America.
University of Utah · USPrimary Children's Hospital · USBaylor College of Medicine · US

Funding

Pediatric Critical Care Scientist Development ProgramK12HD047349 · NICHD · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI HEATHER T. KEENAN, Kevin M Watt · 2004 to 2026
$17.0M
NICHD NIH HHS K12 HD047349Wellcome Trust
6 · The paper itself

Abstract

backgroundInvasive Staphylococcus aureus infections are a common cause of morbidity and mortality in children. In the early 2000's the proportion of infections due the methicillin-resistant S. aureus (MRSA) increased rapidly. We described the clinical and molecular epidemiology of invasive S. aureus disease in a pediatric population.

methodsWe prospectively identified children in Utah with invasive S. aureus infections. Medical records were reviewed to determine diagnosis and clinical characteristics. Isolates were genotyped using multi-locus sequence typing. The presence of genes encoding the Panton-Valentine leukocidin (PVL) was determined using polymerase chain reaction.

resultsOver a 4-year period between January 2009 and December 2012, we identified 357 children, hospitalized at Primary Children's Hospital, with invasive S. aureus infections and isolates available for the study. Methicillin-susceptible S. aureus (MSSA) caused 79% of disease, while MRSA caused only 21% of disease. Mortality associated with invasive S. aureus infection was 3.6%. The most common diagnoses were osteoarticular infections (38%) followed by central line associated blood stream infections (19%) and pneumonia (12%). We identified 41 multi-locus sequence types. The majority of isolates belonged to 6 predominant clonal complexes (CC5, CC8, CC15, CC30, CC45, CC59). PVL was present in a minority (16%) of isolates, of which most were ST8 MRSA.

conclusionsMSSA was the primary cause of invasive S. aureus infections at our institution throughout the study period. A limited number of predominant strains accounted for the majority of invasive disease. The classic virulence factor PVL was uncommon in MSSA isolates. Further study is needed to improve our understanding of S. aureus virulence and disease pathogenesis.

Indexed as

Anti-Bacterial AgentsBacterial Typing TechniquesChildChild, PreschoolFemaleGenotypeHumansMaleMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMolecular EpidemiologyMultilocus Sequence TypingStaphylococcal InfectionsStaphylococcus aureusUtahVirulence FactorsAnti-Bacterial AgentsVirulence Factors

Identifiers

PMID32946486
PMCPMC7500648
OpenAlexW3087695784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.